Development of prognostic model for patients at CKD stage 3a and 3b in South Central China using computational intelligence

ConclusionsCSM could be used as a point-of-care test to screen patients at high risk for disease progression, might allowing individualized therapeutic management.

Source: Clinical and Experimental Nephrology - July 31, 2020 Category: Urology & Nephrology Source Type: research